Versant Venture Capital Vi, L.P. Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

GLUE Quotes by TradingView

Versant Venture Capital VI, L.P. Transaction History

Date Transaction Value Shares Traded Form
Oct 29 2024
SELL
Open market or private sale
$628,121 $9.25 p/Share
67,905
Oct 28 2024
SELL
Other acquisition or disposition
-
415,535
Oct 28 2024
SELL
Open market or private sale
$869,303 $9.66 p/Share
89,990
Oct 28 2024
BUY
Other acquisition or disposition
-
48,945
Jun 28 2021
BUY
Conversion of derivative security
-
1,940,043
Jun 28 2021
BUY
Open market or private purchase
$3,000,005 $19.0 p/Share
157,895

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
> 10% Shareholder
OYST
Oyster Point Pharma, Inc. Healthcare
> 10% Shareholder
IPSC
Century Therapeutics, Inc. Healthcare
> 10% Shareholder
GRPH
Graphite Bio, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
> 10% Shareholder
TPST
Tempest Therapeutics, Inc. Healthcare
VVC

Versant Venture Capital Vi, L.P.

San Francisco, CA

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLUE